Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
VALACYCLOVIR
(1995)
Small molecule
Unknown
Unknown
Approved
Herpes Genitalis; Herpes Labialis; Herpes Zoster; Virus Diseases
VALACYCLOVIR
×
Maximum Phase:
4
First Approval:
1995
UNII:
MZ1IW7Q79D
Molecule Type:
Small molecule
Molecular Formula:
C13H20N6O4
Molecular Weight:
324.34
AlogP:
-0.8
PSA:
151.14
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DIRITHROMYCIN
(1995)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections
DIRITHROMYCIN
×
Maximum Phase:
4
First Approval:
1995
UNII:
1801D76STL
Molecule Type:
Small molecule
Molecular Formula:
C42H78N2O14
Molecular Weight:
835.09
AlogP:
2.2
PSA:
196.33
HBD:
5.0
HBA:
#RotB:
12.0
Source:
NISOLDIPINE
(1995)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Cardiovascular Diseases; Hypertension
NISOLDIPINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
4I8HAB65SZ
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O6
Molecular Weight:
388.42
AlogP:
3.2
PSA:
107.77
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BICALUTAMIDE
(1995)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Carcinoma; Neoplasms
BICALUTAMIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
A0Z3NAU9DP
Molecule Type:
Small molecule
Molecular Formula:
C18H14F4N2O4S
Molecular Weight:
430.38
AlogP:
2.88
PSA:
107.26
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EPOPROSTENOL
(1995)
Small molecule
Unknown
Unknown
Approved
Thrombosis
EPOPROSTENOL
×
Maximum Phase:
4
First Approval:
1995
UNII:
DCR9Z582X0
Molecule Type:
Small molecule
Molecular Formula:
C20H32O5
Molecular Weight:
352.47
AlogP:
3.41
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
ALENDRONIC ACID
(1995)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
ALENDRONIC ACID
×
Maximum Phase:
4
First Approval:
1995
UNII:
X1J18R4W8P
Molecule Type:
Small molecule
Molecular Formula:
C4H13NO7P2
Molecular Weight:
249.1
AlogP:
-1.27
PSA:
161.31
HBD:
6.0
HBA:
#RotB:
5.0
Source:
AMIFOSTINE
(1995)
Small molecule
Reactive metabolite scavenging agent
INJECTION
Approved
Head and Neck Neoplasms; Ovarian Neoplasms; Xerostomia
AMIFOSTINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
M487QF2F4V
Molecule Type:
Small molecule
Molecular Formula:
C5H15N2O3PS
Molecular Weight:
214.23
AlogP:
-0.25
PSA:
95.58
HBD:
4.0
HBA:
#RotB:
7.0
Source:
EPOPROSTENOL SODIUM
(1995)
Small molecule
Prostanoid IP receptor agonist
INJECTION
Approved
Pulmonary Arterial Hypertension
EPOPROSTENOL SODIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
4K04IQ1OF4
Molecule Type:
Small molecule
Molecular Formula:
C20H31NaO5
Molecular Weight:
374.45
AlogP:
3.41
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
IOXILAN
(1995)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
IOXILAN
×
Maximum Phase:
4
First Approval:
1995
UNII:
A4YJ7J11TG
Molecule Type:
Small molecule
Molecular Formula:
C18H24I3N3O8
Molecular Weight:
791.11
AlogP:
-0.99
PSA:
179.66
HBD:
7.0
HBA:
#RotB:
11.0
Source:
ALENDRONATE SODIUM
(1995)
Small molecule
Farnesyl diphosphate synthase inhibitor
ORAL
Approved
Bone Diseases, Metabolic; Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures
ALENDRONATE SODIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
2UY4M2U3RA
Molecule Type:
Small molecule
Molecular Formula:
C4H12NNaO7P2
Molecular Weight:
271.08
AlogP:
-1.27
PSA:
161.31
HBD:
6.0
HBA:
#RotB:
5.0
Source:
IBUTILIDE FUMARATE
(1995)
Small molecule
HERG blocker
INJECTION
Approved
Unknown
IBUTILIDE FUMARATE
×
Maximum Phase:
4
First Approval:
1995
UNII:
9L5X4M5L6I
Molecule Type:
Small molecule
Molecular Formula:
C44H76N4O10S2
Molecular Weight:
885.24
AlogP:
4.16
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
14.0
Source:
IOPROMIDE
(1995)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
IOPROMIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
712BAC33MZ
Molecule Type:
Small molecule
Molecular Formula:
C18H24I3N3O8
Molecular Weight:
791.11
AlogP:
-0.41
PSA:
168.66
HBD:
6.0
HBA:
#RotB:
11.0
Source:
RILUZOLE
(1995)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Amyotrophic Lateral Sclerosis
RILUZOLE
×
Maximum Phase:
4
First Approval:
1995
UNII:
7LJ087RS6F
Molecule Type:
Small molecule
Molecular Formula:
C8H5F3N2OS
Molecular Weight:
234.2
AlogP:
2.78
PSA:
48.14
HBD:
1.0
HBA:
#RotB:
1.0
Source:
MYCOPHENOLATE MOFETIL
(1995)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
ORAL
Approved
Unknown
MYCOPHENOLATE MOFETIL
×
Maximum Phase:
4
First Approval:
1995
UNII:
9242ECW6R0
Molecule Type:
Small molecule
Molecular Formula:
C23H31NO7
Molecular Weight:
433.5
AlogP:
2.52
PSA:
94.53
HBD:
1.0
HBA:
#RotB:
9.0
Source:
NALMEFENE
(1995)
Small molecule
Unknown
Unknown
Approved
Alcoholism
NALMEFENE
×
Maximum Phase:
4
First Approval:
1995
UNII:
TOV02TDP9I
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO3
Molecular Weight:
339.44
AlogP:
2.51
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
2.0
Source:
METFORMIN HYDROCHLORIDE
(1995)
Small molecule
Mitochondrial complex I (NADH dehydrogenase) inhibitor
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
786Z46389E
Molecule Type:
Small molecule
Molecular Formula:
C4H12ClN5
Molecular Weight:
165.63
AlogP:
-1.03
PSA:
88.99
HBD:
4.0
HBA:
#RotB:
0.0
Source:
LANSOPRAZOLE
(1995)
Small molecule
Potassium-transporting ATPase inhibitor
INTRAVENOUS; ORAL
Approved
Gastroesophageal Reflux; Peptic Ulcer; Stomach Ulcer
LANSOPRAZOLE
×
Maximum Phase:
4
First Approval:
1995
UNII:
0K5C5T2QPG
Molecule Type:
Small molecule
Molecular Formula:
C16H14F3N3O2S
Molecular Weight:
369.37
AlogP:
3.52
PSA:
67.87
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SAQUINAVIR MESYLATE
(1995)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Unknown
SAQUINAVIR MESYLATE
×
Maximum Phase:
4
First Approval:
1995
UNII:
UHB9Z3841A
Molecule Type:
Small molecule
Molecular Formula:
C39H54N6O8S
Molecular Weight:
766.96
AlogP:
3.09
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
12.0
Source:
LATANOPROST
(1996)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Hypertension; Ocular Hypertension
LATANOPROST
×
Maximum Phase:
4
First Approval:
1996
UNII:
6Z5B6HVF6O
Molecule Type:
Small molecule
Molecular Formula:
C26H40O5
Molecular Weight:
432.6
AlogP:
4.19
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
13.0
Source:
AMPHETAMINE ASPARTATE
(1996)
Small molecule
Dopamine transporter releasing agent
Unknown
Approved
Unknown
AMPHETAMINE ASPARTATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
H527KAP6L5
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O4
Molecular Weight:
268.31
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DOCETAXEL
(1996)
Small molecule
Tubulin inhibitor
INJECTION; INTRAVENOUS
Approved
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms
DOCETAXEL
×
Maximum Phase:
4
First Approval:
1996
UNII:
15H5577CQD
Molecule Type:
Small molecule
Molecular Formula:
C43H53NO14
Molecular Weight:
807.89
AlogP:
3.26
PSA:
224.45
HBD:
5.0
HBA:
#RotB:
8.0
Source:
OLOPATADINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
NASAL; OPHTHALMIC
Approved
Conjunctivitis, Allergic; Pruritus; Rhinitis, Allergic, Seasonal
OLOPATADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
2XG66W44KF
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClNO3
Molecular Weight:
373.88
AlogP:
3.59
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AMLEXANOX
(1996)
Small molecule
Phosphodiesterase 4 inhibitor
DENTAL; TOPICAL
Approved
Lung Diseases, Obstructive
AMLEXANOX
×
Maximum Phase:
4
First Approval:
1996
UNII:
BRL1C2459K
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O4
Molecular Weight:
298.3
AlogP:
2.75
PSA:
106.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ALLOPURINOL SODIUM
(1996)
Small molecule
Xanthine dehydrogenase inhibitor
INJECTION
Approved
Unknown
ALLOPURINOL SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
428673RC2Z
Molecule Type:
Small molecule
Molecular Formula:
C5H3N4NaO
Molecular Weight:
158.1
AlogP:
-0.4
PSA:
74.43
HBD:
2.0
HBA:
#RotB:
0.0
Source:
FEXOFENADINE
(1996)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
FEXOFENADINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
E6582LOH6V
Molecule Type:
Small molecule
Molecular Formula:
C32H39NO4
Molecular Weight:
501.67
AlogP:
5.51
PSA:
81.0
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MIDODRINE HYDROCHLORIDE
(1996)
Small molecule
Adrenergic receptor alpha-1 agonist
ORAL
Approved
Unknown
MIDODRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
59JV96YTXV
Molecule Type:
Small molecule
Molecular Formula:
C12H19ClN2O4
Molecular Weight:
290.75
AlogP:
-0.19
PSA:
93.81
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PHENYLBUTANOIC ACID
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
PHENYLBUTANOIC ACID
×
Maximum Phase:
4
First Approval:
1996
UNII:
7WY7YBI87E
Molecule Type:
Small molecule
Molecular Formula:
C10H12O2
Molecular Weight:
164.2
AlogP:
2.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CEFEPIME
(1996)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
CEFEPIME
×
Maximum Phase:
4
First Approval:
1996
UNII:
807PW4VQE3
Molecule Type:
Small molecule
Molecular Formula:
C19H24N6O5S2
Molecular Weight:
480.57
AlogP:
-1.28
PSA:
150.04
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MIRTAZAPINE
(1996)
Small molecule
Adrenergic receptor alpha-2 antagonist
ORAL
Approved
Depressive Disorder; Depressive Disorder, Major; Sleep Initiation and Maintenance Disorders
MIRTAZAPINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
A051Q2099Q
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3
Molecular Weight:
265.36
AlogP:
2.48
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ALBENDAZOLE
(1996)
Small molecule
Tubulin inhibitor
ORAL
Approved
Helminthiasis; Infections; Neurocysticercosis
ALBENDAZOLE
×
Maximum Phase:
4
First Approval:
1996
UNII:
F4216019LN
Molecule Type:
Small molecule
Molecular Formula:
C12H15N3O2S
Molecular Weight:
265.34
AlogP:
3.24
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TOPOTECAN
(1996)
Small molecule
Unknown
Unknown
Approved
Neoplasms
TOPOTECAN
×
Maximum Phase:
4
First Approval:
1996
UNII:
7M7YKX2N15
Molecule Type:
Small molecule
Molecular Formula:
C23H23N3O5
Molecular Weight:
421.45
AlogP:
1.85
PSA:
104.89
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DEXTROAMPHETAMINE SACCHARATE
(1996)
Small molecule
Dopamine transporter releasing agent
Unknown
Approved
Attention Deficit Disorder with Hyperactivity; Narcolepsy
DEXTROAMPHETAMINE SACCHARATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
G83415V073
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO8
Molecular Weight:
345.35
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
AZELASTINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
NASAL; OPHTHALMIC
Approved
Conjunctivitis, Allergic; Nasal Obstruction; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor
AZELASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
0L591QR10I
Molecule Type:
Small molecule
Molecular Formula:
C22H25Cl2N3O
Molecular Weight:
418.37
AlogP:
4.3
PSA:
38.13
HBD:
0.0
HBA:
#RotB:
3.0
Source:
FOSFOMYCIN TROMETHAMINE
(1996)
Small molecule
UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
ORAL
Approved
Urinary Tract Infections
FOSFOMYCIN TROMETHAMINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
7FXW6U30GY
Molecule Type:
Small molecule
Molecular Formula:
C7H18NO7P
Molecular Weight:
259.19
AlogP:
-0.09
PSA:
70.06
HBD:
2.0
HBA:
#RotB:
1.0
Source:
VALPROATE SODIUM
(1996)
Small molecule
Succinate semialdehyde dehydrogenase inhibitor
INJECTION
Approved
Epilepsy
VALPROATE SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
5VOM6GYJ0D
Molecule Type:
Small molecule
Molecular Formula:
C8H15NaO2
Molecular Weight:
166.2
AlogP:
2.29
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LEVOFLOXACIN
(1996)
Small molecule
DNA gyrase inhibitor
INJECTION; OPHTHALMIC; ORAL
Approved
Acne Vulgaris; Bacterial Infections; Bronchitis, Chronic; Conjunctivitis, Bacterial; Corneal Ulcer; Eye Infections; Infections; Otitis Externa; Pneumonia; Sinusitis; Urinary Tract Infections
LEVOFLOXACIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
6GNT3Y5LMF
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.37
AlogP:
1.54
PSA:
75.01
HBD:
1.0
HBA:
#RotB:
2.0
Source:
1
2
…
43
44
45
46
47
48
49
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA